Clinical trial
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular…
NCT00213148 · EMD Serono, Industry · Completed
Key facts
| NCT number | NCT00213148 |
|---|---|
| Title | Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction |
| Official title | A Phase II, Prospective, Randomized, Double-Blind, Multicenter, Dose Finding, Comparative Study for the Evaluation of the Aromatase Inhibitor Anastrozole (Multiple-Dose) Versus Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction |
| Lead sponsor | EMD Serono, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anovulation |
| Intervention type | Drug |
| Interventions | Anastrozole 1 mg, Anastrozole 5 mg, Anastrozole 10 mg, Clomiphene Citrate 50 mg, Clomiphene Citrate 100 mg |
| Enrollment | 271 |
| Start date | Mar 10, 2005 |
| Primary completion | Dec 12, 2007 |
| Completion | Dec 12, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: